Login to Your Account



Other News To Note


Wednesday, January 4, 2012
• Astex Pharmaceuticals Inc., of Dublin, Calif., said the FDA's Oncologic Drugs Advisory Committee will discuss its supplemental new drug application for Dacogen (decitabine) for Injection at its Feb. 9, 2012, meeting. The proposed indication for the application is elderly acute myelogenous leukemia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription